On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Helios Hospital Schwerin

InstitutionResearch output, impact & collaborations

Helios Hospital Schwerin is a institution indexed in ScholarIQ from OpenAlex.

What is known about Helios Hospital Schwerin?

ScholarIQrecord summary

Helios Hospital Schwerin is a research organisation in Schwerin, DE. OpenAlex records 1,473 works and 32,692 citations for it. 428 researchers list it as their most recent affiliation.

How many works does Helios Hospital Schwerin have?

ScholarIQindexed works

Helios Hospital Schwerin has 1,473 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Helios Hospital Schwerin →

How many citations does Helios Hospital Schwerin have?

ScholarIQcitation count

Helios Hospital Schwerin has 32,692 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Helios Hospital Schwerin →

How many researchers are at Helios Hospital Schwerin?

ScholarIQresearcher count

Helios Hospital Schwerin has 428 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Helios Hospital Schwerin?

ScholarIQavg h-index

Helios Hospital Schwerin has an average h-index of 40 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Helios Hospital Schwerin?

ScholarIQror

The ROR for Helios Hospital Schwerin is on the source record.

Open the ROR →

What is the OpenAlex record for Helios Hospital Schwerin?

ScholarIQopenalex

The OpenAlex for Helios Hospital Schwerin is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Helios Hospital Schwerin?

ScholarIQtop researchers by citations

Heike Beneš · Restless Legs Syndrome Research

116 works3,888 citations

What are the most-cited papers on Helios Hospital Schwerin?

ScholarIQmost cited works

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Claudia Trenkwalder, Heike Beneš, Ludger Grote, Diego Garcı́a-Borreguero, Birgit Högl, Michael Hopp, Björn Bosse, A. Oksche, K. Reimer, Juliane Winkelmann, Richard P. Allen, Ralf Kohnen

The Lancet Neurology. 2013226 Citations

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

Claudia Trenkwalder, Heike Beneš, Werner Poewe, Wolfgang H. Oertel, Diego Garcı́a-Borreguero, Al W. de Weerd, Luigi Ferini‐Strambi, Pasquale Montagna, Per Odin, Karin Stiasny‐Kolster, Birgit Högl, К. Ray Chaudhuri, Markku Partinen, Erwin Schollmayer, Ralf Kohnen

The Lancet Neurology. 2008201 Citations

Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics

Heike Beneš, Arthur S. Walters, Richard P. Allen, Wayne A. Hening, Ralf Kohnen

Movement Disorders. 2007168 Citations

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

Diego Garcı́a-Borreguero, Luigi Ferini‐Strambi, Ralf Kohnen, Shaun T. O’Keeffe, Claudia Trenkwalder, Birgit Högl, Heike Beneš, Poul Jennum, Markku Partinen, Danyal Fer, Pasquale Montagna, Claudio L. Bassetti, Álex Iranzo, Karel Šonka, Anne‐Marie Williams

European Journal of Neurology. 2012151 CitationsOPEN ACCESS

Long-term safety and efficacy of rotigotine transdermal patch for moderate-to-severe idiopathic restless legs syndrome: a 5-year open-label extension study

Wolfgang H. Oertel, Claudia Trenkwalder, Heike Beneš, Luigi Ferini‐Strambi, Birgit Högl, Werner Poewe, Karin Stiasny‐Kolster, Andreas Fichtner, Erwin Schollmayer, Ralf Kohnen, Diego Garcı́a-Borreguero

The Lancet Neurology. 2011143 Citations

How much of the research on Helios Hospital Schwerin is open access?

ScholarIQopen access share

45%OPEN ACCESS

Gold

Green

Hybrid

Bronze

18%

Closed

55%